A peptide Certificate of Analysis (COA) is a batch-specific document that reports the tests run on a lot, the methods used, and the results, with HPLC purity and mass spectrometry identity as the two most important entries. Reading one well means checking that the purity figure is backed by a chromatogram, that identity is confirmed by mass, and that the lot number matches your vial. This guide explains each section. All material referenced is for in vitro research use only.
Direct answer: A peptide COA lists batch-specific test results. The two entries that matter most are HPLC purity (the main peak's area as a percent of all peaks) and mass spectrometry identity (observed mass matching the theoretical mass). A purity number with no chromatogram and no MS confirmation is incomplete.
What is a peptide Certificate of Analysis?
A Certificate of Analysis is a quality document tied to a specific production batch. In regulated pharmaceutical settings, the underlying concept is a specification: under ICH guideline Q6A, a specification is a list of tests, references to the analytical procedures used, and acceptance criteria the material must meet to be considered acceptable. A COA is the filled-in version of that, showing the actual result for each test. A complete peptide COA generally identifies the product name and sequence, the lot or batch number, the test methods, the acceptance criteria or specification, the measured results, and the date and laboratory of analysis. Each row should pair a test with both its method and its result, so you can see not just the number but how it was obtained (ICH Q6A).
How is HPLC purity reported on a COA?
The purity line on a peptide COA almost always comes from high-performance liquid chromatography, usually reversed-phase HPLC. In reversed-phase HPLC, a nonpolar column separates peptides by hydrophobicity as a water-and-organic gradient flows through, and each component elutes at a characteristic retention time, appearing as a peak on the chromatogram. Detection is commonly by ultraviolet absorbance near 210 to 220 nanometers, because the peptide bond absorbs strongly there. The percent purity figure is then derived from the relative sizes of those peaks. The largest peak is the target peptide, and smaller peaks represent impurities or degradation products. Reading the chromatogram, not just the headline number, is how you judge whether a purity claim is credible.
How is the purity percentage calculated?
Purity is calculated by area normalization. Per the United States Pharmacopeia general chapter on chromatography (USP <621>), the percent content of a component is the area of that component's peak expressed as a percentage of the total area of all peaks, excluding peaks from solvents, reagents, the mobile phase, or the sample matrix, and excluding peaks at or below the reporting threshold. So a stated purity of 99 percent means the target peak accounts for 99 percent of the summed peak area after those exclusions. Commercial research peptides are often specified at 98 percent or higher, though that is a market convention rather than a pharmacopeial mandate. The citable regulatory benchmark is the FDA's treatment of peptide-related impurities above 0.5 percent as warranting identification (USP-NF, USP <621>; FDA, 2021).
How does mass spectrometry confirm peptide identity?
This is the entry many buyers overlook. HPLC purity tells you how much of the sample is one dominant peak, but it does not prove that peak is the peptide named on the label. Identity confirmation requires mass spectrometry, typically liquid chromatography-mass spectrometry (LC-MS). The method compares the observed molecular mass of the eluted compound against the theoretical molecular weight calculated from the expected amino acid sequence; a match confirms identity. Electrospray ionization, the soft ionization technique used for this, produces multiply charged ions without fragmenting the molecule, and the true mass is recovered by charge deconvolution across adjacent charge states. Its inventor shared the 2002 Nobel Prize in Chemistry, reflecting how central the method is to confirming peptide identity (Banerjee & Mazumdar, 2012).
What other tests appear on a peptide COA?
Beyond purity and identity, several supporting tests commonly appear, and each affects how much actual peptide is in a vial.
- Water or moisture content, measured by Karl Fischer titration under USP general chapter <921>. Residual water reduces the true peptide mass per vial.
- Peptide content and counter-ion content. Every synthetic peptide is a salt with a counter-ion, usually acetate or trifluoroacetate (TFA), the latter common because TFA is used during synthesis. The salt and water weight is why net peptide content is listed separately from gross vial weight.
- Endotoxin and sterility, where reported, are measured under USP <85> (bacterial endotoxins) and USP <71> (sterility), indicating pyrogen and microbial burden of the material.
How do you judge whether a COA is credible?
A COA is only as trustworthy as its traceability and transparency. Use a short checklist when reading one.
- Lot match. The lot or batch number on the COA must match the number on your actual vial. A COA for a different lot tells you nothing about what you received.
- Independent testing. A named, identifiable third-party laboratory and analysis date carry more weight than an unattributed in-house number, because they reduce conflict of interest.
- Traces, not just numbers. A credible COA includes the actual HPLC chromatogram and the MS spectrum showing both theoretical and observed mass, not only a bare "99 percent." A number you cannot trace back to a graph cannot be independently evaluated.
When a certificate satisfies all three, the purity and identity figures become something you can actually rely on rather than take on faith.
Where can researchers see NLL COAs?
Next Level Labs publishes lot-specific certificates in the Lab Reports library, and product pages such as the Wolverine Stack and CJC-1295 + Ipamorelin link directly to their batch COAs. To understand how independent third-party grades relate to these documents, see our explainer on the Finnrick grading system, and the FAQ for research-use questions.
SOURCES
- International Council for Harmonisation. ICH Q6A "Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products." (FDA-adopted guideline)
- United States Pharmacopeia-National Formulary. General Chapter <621> "Chromatography" (harmonized; official December 1, 2022). usp.org
- U.S. Food and Drug Administration. "ANDAs for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of rDNA Origin." Guidance for Industry, 2021. fda.gov
- Banerjee S, Mazumdar S. "Electrospray Ionization Mass Spectrometry: A Technique to Access the Information beyond the Molecular Weight of the Analyte." International Journal of Analytical Chemistry. 2012;2012:282574. doi.org
- United States Pharmacopeia-National Formulary. General Chapter <921> "Water Determination" (Karl Fischer titration).
- United States Pharmacopeia-National Formulary. General Chapter <85> "Bacterial Endotoxins Test." usp.org
For in vitro research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any condition. This article is for educational purposes.